6-hydroxyflavone has been researched along with genistein in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Constantinou, A; Mehta, R; Moon, R; Rao, K; Runyan, C; Vaughan, A | 1 |
Le Lain, R; Maharlouie, FH; Nicholls, PJ; Smith, HJ | 1 |
Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
Brun, R; Lack, G; Perozzo, R; Rüedi, P; Scapozza, L; Tasdemir, D | 1 |
Akamatsu, M; Hosoda, A; Hotta, Y; Ishimoto, Y; Nishizaki, Y; Tamura, H; Yoshikawa, H | 1 |
Amić, D; Lucić, B | 1 |
Abramić, M; Agić, D; Bešlo, D; Brkić, H; Karačić, Z; Lisjak, M; Špoljarević, M; Tomić, S | 1 |
7 other study(ies) available for 6-hydroxyflavone and genistein
Article | Year |
---|---|
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
Topics: DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Electrophoresis, Agar Gel; Flavonoids; Hydroxylation; Plasmids; Protein Conformation; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1995 |
Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstenedione; Animals; Benzoquinones; Drug Evaluation, Preclinical; Enzyme Inhibitors; Estradiol; Estrone; Flavanones; Flavonoids; Genistein; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Kinetics; Male; Microsomes; Prostatic Neoplasms; Rats; Structure-Activity Relationship; Testis; Testosterone | 2001 |
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase; Alcohol Oxidoreductases; Animals; Antimalarials; Catechin; Cells, Cultured; Chloroquine; Drug Resistance; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Fatty Acids; Flavones; Flavonoids; Humans; Hydro-Lyases; Kinetics; Luteolin; Phenols; Plasmodium falciparum; Polyphenols; Structure-Activity Relationship | 2006 |
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
Topics: Androgen Receptor Antagonists; Androgens; Cell Line, Tumor; Flavonoids; Genes, Reporter; Humans; Receptors, Androgen; Receptors, Glucocorticoid; Structure-Activity Relationship | 2009 |
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
Topics: Flavonoids; Free Radical Scavengers; Models, Biological; Quantitative Structure-Activity Relationship; Quantum Theory; Software; Thermodynamics | 2010 |
Validation of flavonoids as potential dipeptidyl peptidase III inhibitors: Experimental and computational approach.
Topics: Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Flavonoids; Humans; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation; Principal Component Analysis; Protease Inhibitors; Quantitative Structure-Activity Relationship | 2017 |